Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $2.03 Million - $2.3 Million
-56,551 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$33.49 - $37.77 $6,195 - $6,987
-185 Reduced 0.33%
56,551 $2.05 Million
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $14,726 - $18,726
-440 Reduced 0.77%
56,736 $2.09 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $19,050 - $22,350
-600 Reduced 1.04%
57,176 $2.1 Million
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $6,024 - $7,308
-200 Reduced 0.34%
57,776 $1.89 Million
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $15,001 - $21,434
-555 Reduced 0.95%
57,976 $1.89 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $1.38 Million - $1.57 Million
41,906 Added 252.07%
58,531 $2.29 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $9,747 - $12,639
-300 Reduced 1.77%
16,625 $597,000
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $2,218 - $2,491
-60 Reduced 0.35%
16,925 $733,000
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $4,687 - $5,150
-125 Reduced 0.73%
16,985 $721,000
Q4 2018

Feb 06, 2019

SELL
$38.47 - $43.86 $906,930 - $1.03 Million
-23,575 Reduced 57.95%
17,110 $747,000
Q3 2018

Nov 06, 2018

SELL
$34.47 - $41.81 $73,076 - $88,637
-2,120 Reduced 4.95%
40,685 $1.79 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $26,878 - $28,655
-815 Reduced 1.87%
42,805 $1.55 Million
Q1 2018

May 04, 2018

SELL
$31.91 - $37.02 $6,701 - $7,774
-210 Reduced 0.48%
43,620 $1.55 Million
Q4 2017

Feb 05, 2018

SELL
$33.26 - $35.29 $4,157 - $4,411
-125 Reduced 0.28%
43,830 $1.59 Million
Q3 2017

Nov 06, 2017

SELL
$31.0 - $34.15 $31,775 - $35,003
-1,025 Reduced 2.28%
43,955 $1.57 Million
Q2 2017

Aug 08, 2017

BUY
N/A
44,980
44,980 $1.51 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Private Harbour Investment Management & Counsel, LLC Portfolio

Follow Private Harbour Investment Management & Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Harbour Investment Management & Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Harbour Investment Management & Counsel, LLC with notifications on news.